Differential effect of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans on co-cultures of human oral cells

Journal of Medical Microbiology

Volumn 54, Issue 8, 2005, Pages 785-794

  Kang, Philip ^a   Korostoff, Jonathan ^a   Volgina, Alla ^a   Grzesik, Wojciech ^a   DiRienzo, Joseph M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AB 1 SURFACE ANTIGEN; BACTERIAL TOXIN; CYTOLETHAL DISTENDING TOXIN; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBODY LABELING; ARTICLE; BACTERIAL VIRULENCE; CELL COMPOSITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; EUKARYOTIC CELL; HUMAN; HUMAN CELL; MITOSIS; MIXED CELL CULTURE; NONHUMAN; PERIODONTAL LIGAMENT; PERIODONTIUM; PRIORITY JOURNAL; SIMIAN VIRUS 40;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTERIAL TOXINS; CELL DIVISION; CELL LINE; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; HUMANS; PERIODONTAL LIGAMENT;

EID: 23744516661     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46077-0     Document Type: Article

References (40)

1. Ahmed, H. J., Svensson, L. A., Cope, L. D., Latimer, J. L., Hansen, E. J., Ahlman, K., Bayat-Turk, J., Klamer, D. & Lagergard, T. (2001). Prevalence of cdt ABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol 50, 860-864.
2. Akifusa, S., Poole, S., Lewthwaite, J., Henderson, B. & Nair, S. P. (2001). Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 69, 5925-5930.
3. Belibasakis, G., Johansson, A., Wang, Y., Claesson, R., Chen, C., Asikainen, S. & Kalfas, S. (2002). Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Eur J Oral Sci 110, 366-373.
4. Belibasakis, G. N., Mattsson, A. Wang, Y., Chen, C. & Johansson, A. (2004). Cell cycle arrest of human gingival fibroblasts and periodontal ligament cells by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. APMIS 112, 675-685.
5. Belibasakis, G. N., Johansson, A., Wang, Y., Chen, C., Kalfas, S. & Lerner, U. H. (2005). The cytolethal distending toxin induces receptor activator of NF-κB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 73, 342-351.
6. Blix, I. J. S., Hars, R., Preus, H. R. & Helgeland, K. (1992). Entrance of Actinobacillus actinomycetemcomitans into HEp-2 cells in vitro. J Periodontal 63, 723-728.
7. Comayras, C., Tasca, C., Pérès, S. Y., Ducommun, B., Oswald, E. & De Rycke, J. (1997). Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 65, 5088-5095.
8. Cortes-Bratti, X., Chaves-Olarte, E., Lagergard, T. & Thelestam, M. (1999). The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 103, 107-115.
9. Cortes-Bratti, X., Karlsson, C., Lagergard, T., Thelestam, M. & Frisan, T. (2001). The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 276, 5296-5302.
10. DiRienzo, J. M., Song, M., Wan, L. S. Y. & Ellen, R. P. (2002). Kinetics of KB and HEp-2 cell responses to an invasive, cytolethal distending toxin-producing strain of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 17, 245-251.
11. Elwell, C. A. & Dreyfus, L. A. (2000). DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 37, 952-963.
12. Fabris, A. S., DiRienzo, J. M., Wikstrom, M. & Mayer, M. P. A. (2002). Detection of cytolethal distending toxin activity and cat genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol Immunol 17, 231-238.
13. Frisan, T., Cortes-Bratti, X., Chaves-Olarte, E., Stenerlow, B. & Thelestam, M. (2003). The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol 5, 695-707.
14. Gilchrist, E. P., Moyer, M. P., Shillitoe, E. J., Clare, N. & Murrah, V. A. (2000). Establishment of a human polyclonal oral epithelial cell line. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90, 340-347.
15. Gron, B., Stoltze, K., Andersson, A. & Dabelsteen, E. (2002). Oral fibroblasts produce more HGF and KGF than skin fibroblasts in response to co-culture with keratinocytes. APMIS 110, 892-898.
16. Grzesik, W. J., Kuznetsov, S. A., Uzawa, K., Mankani, M., Robey, P. G. & Yamauchi, M. (1998). Normal human cementum-derived cells: isolation, clonal expansion, and in vitro and in vivo characterization. J Bone Miner Res 13, 1547-1554.
17. Grzesik, W. J., Cheng, H., Oh, J. S., Kuznetsov, S. A., Mankani, M., Uzawa, K., Robey, P. G. & Yamauchi, M. (2000). Cementum-forming cells are phenotypically distinct from bone-forming cells. J Bone Miner Res 15, 52-59.
18. Hassane, D. C., Lee, R. B. & Pickett, C. L. (2003). Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect Immun 71, 541-545.
19. Hassel, T. (1993). Tissues and cells of the periodontium. Periodontol 2000 3, 9-38.
20. Henderson, B., Nair, S. P., Ward, J. M. & Wilson, M. (2003). Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57, 29-55.
21. Heywood, W., Henderson, B. & Nair, S. P. (2005). Cytolethal distending toxin: creating a gap in the cell cycle. J Med Microbiol 54, 207-216.
22. Kanno, F., Korostoff, J., Volgina, A. & DiRienzo, J. M. (2005). Resistance of human periodontal ligament fibroblasts to the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. J Periodontol (in press).
23. Lara-Tejero, M. & Galȧn, J. E. (2000). A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290, 354-357.
24. Lekic, P. C., Pender, N. & McCulloch, C. A. (1997). Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit Rev Oral Biol Med 8, 253-268.
25. Liu, D., Xu, J. K., Figliomeni, L., Huang, L., Pavlos, N. J., Rogers, M., Tan, A., Price, P. & Zheng, M. H. (2003). Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 11, 17-21.
26. Mao, X. & DiRienzo, J. M. (2002). Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol 4, 245-255.
27. Mayer, M. P. A., Bueno, L. C., Hansen, E. J. & DiRienzo, J. M. (1999). Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun 67, 1227-1237.
28. Meyer, D. H., Lippmann, J. E. & Fives-Taylor, P. M. (1996). Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: a dynamic, multistep process. Infect Immun 64, 2988-2997.
29. Mogi, M., Otogoto, J., Ota, N. & Togari, A. (2004). Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 83, 166-169.
30. Saalbach, A., Anderegg, U., Bruns, M., Schnabel, E., Herrmann, K. & Haustein, U. F. (1996). Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol 106, 1314-1319.
31. Saalbach, A., Wetzig, T., Haustein, U. F. & Anderegg, U. (1999). Detection of human soluble Thy-1 in serum by ELISA: fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tissue Res 298, 307-315.
32. Sawaki, K., Yamaai, T., Mizukawa, N. & Yoshimoto, T. (2003). Mortality of human epidermal keratinocytes in co-culture with oral squamous cell carcinoma cells. Anticancer Res 23, 79-84.
33. Schmalz, G., Arenholt-Bindslev, D., Miller, K. A. & Schweikl, H. (1997). Epithelium-fibroblast co-culture for assessing mucosal irritancy of metals used in dentistry. Eur J Oral Sci 105, 86-91.
34. 2 arrest in human T cells. J Immunol 162, 4773-4780.
35. Somerman, M. J., Archer, S. Y., Imm, G. R. & Foster, R. A. (1988). A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 67, 66-70.
36. Sugai, M., Kawamoto, T., Pérès, S. Y., Ueno, Y., Komatsuzawa, H., Fujiwara, T., Kurihara, H., Suginaka, H. & Oswald, E. (1998). Cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 66, 5008-5019.
37. Tan, K.-S., Song, K.-P. & Ong, G. (2002). Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J Periodont Res 37, 268-272.
38. Vindelov, L. L. (1977). Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions: a new method for rapid isolation and staining of nuclei. Arch B Cell Pathol 24, 227-242.
39. 2-phase cell cycle block. Infect Immun 66, 1934-1940.
40. Yamano, R., Ohara, M., Nishikubo, S. & 10 other authors (2003). Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J Clin Microbiol 41, 1391-1398.